Literature DB >> 18303700

Addressing smoking in community drug abuse treatment programs: practical and policy considerations.

Gregory S Brigham1, Grant Schroeder, Eric Schindler.   

Abstract

Smoking is the leading cause of preventable death in the United States. This public health problem is of particular concern among individuals with substance use disorders in that they smoke at a greater rate than the general public. Smoking-related illness represents a major source of preventable death in persons with drug dependencies. Substance abuse treatment programs have access to persons with substance use disorders and the opportunity to intervene on their smoking; however, nicotine dependence has historically not been viewed in the same light as other drug dependencies by the treatment field. As a result, many persons in these treatment program settings do not receive opportunities to address their smoking. When substance abuse treatment organizations consider implementing smoking policies and services, many questions and choices arise. In practice, a range of approaches has been developed from simple assessment and referral for smoking cessation treatment to implementing smoke-free grounds and requiring that patients stop smoking concurrent with addressing their other drug dependencies. Smoking cessation policy decisions have the potential to directly affect the patients, the workforce, the referral network, and other major stakeholders related to these organizations. The authors consider a range of both practical and policy issues facing treatment organizations and conclude that advances in smoking policy are possible with current resources.

Entities:  

Mesh:

Year:  2007        PMID: 18303700     DOI: 10.1080/02791072.2007.10399882

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  4 in total

1.  Smoking Cessation Services in Adolescent Substance Abuse Treatment: Opportunities Missed?

Authors:  Hannah K Knudsen
Journal:  J Drug Issues       Date:  2009-03

2.  Availability of nicotine replacement therapy in substance use disorder treatment: longitudinal patterns of adoption, sustainability, and discontinuation.

Authors:  Hannah K Knudsen; Jamie L Studts
Journal:  Drug Alcohol Depend       Date:  2011-04-29       Impact factor: 4.492

3.  Organizational factors as predictors of tobacco cessation pharmacotherapy adoption in addiction treatment programs.

Authors:  Jessica L Muilenburg; Tanja C Laschober; Lillian T Eby
Journal:  J Addict Med       Date:  2014 Jan-Feb       Impact factor: 3.702

4.  Testing the drug substitution switching-addictions hypothesis. A prospective study in a nationally representative sample.

Authors:  Carlos Blanco; Mayumi Okuda; Shuai Wang; Shang-Min Liu; Mark Olfson
Journal:  JAMA Psychiatry       Date:  2014-11       Impact factor: 21.596

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.